111 Inc. is a healthcare company

BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.  (0874.HK; 600332.SH) said on Sunday it paid 749 million yuan ($105 million) via its Guangzhou GP Fund II subsidiary for 11.04% of NanJing Pharmaceutical…
111 Inc. is a healthcare company

BRIEF: CF PharmTech to raise $77 million in Hong Kong IPO

Pharmaceutical manufacturer CF PharmTech Inc. (2652.HK) on Friday launched its Hong Kong IPO, seeking to raise about HK$601 million ($77 million) by selling 41.2 million shares for HK$14.75 apiece. The…